153 related articles for article (PubMed ID: 37473682)
21. Blockade of STAT3 signaling alleviates the progression of acute kidney injury to chronic kidney disease through antiapoptosis.
Park JY; Yoo KD; Bae E; Kim KH; Lee JW; Shin SJ; Lee JS; Kim YS; Yang SH
Am J Physiol Renal Physiol; 2022 May; 322(5):F553-F572. PubMed ID: 35311382
[TBL] [Abstract][Full Text] [Related]
22. Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.
Bharadwaj U; Kasembeli MM; Robinson P; Tweardy DJ
Pharmacol Rev; 2020 Apr; 72(2):486-526. PubMed ID: 32198236
[TBL] [Abstract][Full Text] [Related]
23. Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells.
Xin H; Zhang C; Herrmann A; Du Y; Figlin R; Yu H
Cancer Res; 2009 Mar; 69(6):2506-13. PubMed ID: 19244102
[TBL] [Abstract][Full Text] [Related]
24. The IGF-I/JAK2-STAT3/miR-21 signaling pathway may be associated with human renal cell carcinoma cell growth.
Su Y; Zhao A; Cheng G; Xu J; Ji E; Sun W
Cancer Biomark; 2017 Jul; 19(3):289-296. PubMed ID: 28453463
[TBL] [Abstract][Full Text] [Related]
25. Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway.
Chen XC; Wu D; Wu HL; Li HY; Yang C; Su HY; Liu ZJ; Huang XR; Lu X; Huang LF; Zhu SP; Pan QJ; An N; Liu HF
Lupus Sci Med; 2022 Apr; 9(1):. PubMed ID: 35414608
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 6 induces cell proliferation of clear cell renal cell carcinoma by suppressing hepaCAM via the STAT3-dependent up-regulation of DNMT1 or DNMT3b.
Quan Z; He Y; Luo C; Xia Y; Zhao Y; Liu N; Wu X
Cell Signal; 2017 Apr; 32():48-58. PubMed ID: 28093267
[TBL] [Abstract][Full Text] [Related]
27. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Ma L; Gong R; Tolbert E; Mao H; Ponnusamy M; Chin YE; Yan H; Dworkin LD; Zhuang S
Kidney Int; 2010 Aug; 78(3):257-68. PubMed ID: 20520592
[TBL] [Abstract][Full Text] [Related]
28. TROAP Promotes the Proliferation, Migration, and Metastasis of Kidney Renal Clear Cell Carcinoma with the Help of STAT3.
Wang J; Wan H; Mi Y; Wu S; Li J; Zhu L
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298609
[TBL] [Abstract][Full Text] [Related]
29. A novel U-STAT3-dependent mechanism mediates the deleterious effects of chronic nicotine exposure on renal injury.
Arany I; Reed DK; Grifoni SC; Chandrashekar K; Booz GW; Juncos LA
Am J Physiol Renal Physiol; 2012 Mar; 302(6):F722-9. PubMed ID: 22169004
[TBL] [Abstract][Full Text] [Related]
30. Anti-OSM Antibody Inhibits Tubulointerstitial Lesion in a Murine Model of Lupus Nephritis.
Liu Q; Du Y; Li K; Zhang W; Feng X; Hao J; Li H; Liu S
Mediators Inflamm; 2017; 2017():3038514. PubMed ID: 28626343
[TBL] [Abstract][Full Text] [Related]
31. Targeting STAT3: A crucial modulator of sepsis.
Lei W; Liu D; Sun M; Lu C; Yang W; Wang C; Cheng Y; Zhang M; Shen M; Yang Z; Chen Y; Deng C; Yang Y
J Cell Physiol; 2021 Nov; 236(11):7814-7831. PubMed ID: 33885157
[TBL] [Abstract][Full Text] [Related]
32. EZH2 enhances the invasive capability of renal cell carcinoma cells via activation of STAT3.
Zhang D; Yang XJ; Luo QD; Fu DL; Li HL; Li HC; Zhang P; Chong T
Mol Med Rep; 2018 Mar; 17(3):3621-3626. PubMed ID: 29286132
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-125a suppresses cell migration, invasion, and regulates hyaluronic acid synthase 1 expression by targeting signal transducers and activators of transcription 3 in renal cell carcinoma cells.
Sun M; Guo S; Yao J; Xiao Y; Sun R; Ma W; Dong Z
J Cell Biochem; 2019 Feb; 120(2):1894-1902. PubMed ID: 30187954
[TBL] [Abstract][Full Text] [Related]
34. Carnosic acid induces apoptosis through inactivation of Src/STAT3 signaling pathway in human renal carcinoma Caki cells.
Park JE; Park B; Chae IG; Kim DH; Kundu J; Kundu JK; Chun KS
Oncol Rep; 2016 May; 35(5):2723-32. PubMed ID: 26936454
[TBL] [Abstract][Full Text] [Related]
35. STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells.
Pawlus MR; Wang L; Hu CJ
Oncogene; 2014 Mar; 33(13):1670-9. PubMed ID: 23604114
[TBL] [Abstract][Full Text] [Related]
36. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.
Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM
J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180
[TBL] [Abstract][Full Text] [Related]
37. Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation.
Chen W; Yuan H; Cao W; Wang T; Chen W; Yu H; Fu Y; Jiang B; Zhou H; Guo H; Zhao X
Theranostics; 2019; 9(14):3980-3991. PubMed ID: 31281526
[No Abstract] [Full Text] [Related]
38. Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model.
Shanmugam MK; Rajendran P; Li F; Kim C; Sikka S; Siveen KS; Kumar AP; Ahn KS; Sethi G
Mol Carcinog; 2015 Oct; 54(10):971-85. PubMed ID: 24797723
[TBL] [Abstract][Full Text] [Related]
39. Guanine nucleotide-binding protein 2, GNBP2, accelerates the progression of clear cell renal cell carcinoma via regulation of STAT3 signaling transduction pathway.
Cao Q; Ma J; Li W; Hong P; Shen T; Tong M
Genes Genomics; 2023 Jan; 45(1):1-11. PubMed ID: 36346541
[TBL] [Abstract][Full Text] [Related]
40. Targeting STAT3 signaling in kidney disease.
Pace J; Paladugu P; Das B; He JC; Mallipattu SK
Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1151-F1161. PubMed ID: 30943069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
